303 related articles for article (PubMed ID: 11071328)
1. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
[TBL] [Abstract][Full Text] [Related]
2. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
[TBL] [Abstract][Full Text] [Related]
3. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C
Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
You DD; Paik KY; Park IY; Yoo YK
Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
[TBL] [Abstract][Full Text] [Related]
5. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.
Suc B; Msika S; Piccinini M; Fourtanier G; Hay JM; Flamant Y; Fingerhut A; Fagniez PL; Chipponi J;
Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886
[TBL] [Abstract][Full Text] [Related]
6. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review.
Lai EC; Lau SH; Lau WY
Arch Surg; 2009 Nov; 144(11):1074-80. PubMed ID: 19917946
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the functional outcome after pylorus-preserving pancreatoduodenectomy: pancreatogastrostomy and pancreatojejunostomy.
Jang JY; Kim SW; Park SJ; Park YH
World J Surg; 2002 Mar; 26(3):366-71. PubMed ID: 11865376
[TBL] [Abstract][Full Text] [Related]
8. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
Dobosz M; Dymecki D; Babicki A; Hać S; Gruca Z; Wajda Z
Wiad Lek; 2001; 54(7-8):380-5. PubMed ID: 11641892
[TBL] [Abstract][Full Text] [Related]
9. Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae.
Jenkins SA; Nott DM; Baxter JN
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):255-8. PubMed ID: 7743308
[TBL] [Abstract][Full Text] [Related]
10. Duct-to-mucosa pancreaticojejunostomy reduces the risk of pancreatic leakage after pancreatoduodenectomy.
Hosotani R; Doi R; Imamura M
World J Surg; 2002 Jan; 26(1):99-104. PubMed ID: 11898041
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial bolus octreotide administration during Whipple procedure in patients with fragile pancreas: a novel technique for safer pancreaticojejunostomy.
Konstadoulakis MM; Filippakis GM; Lagoudianakis E; Antonakis PT; Dervenis C; Bramis J
J Surg Oncol; 2005 Mar; 89(4):268-72. PubMed ID: 15726611
[TBL] [Abstract][Full Text] [Related]
12. Pancreaticojejunostomy and pancreatic leakage after pancreaticoduodenectomy.
Kojima Y; Katayama K; Note M; Shimada H; Nakagawara G
Int Surg; 1992; 77(2):80-3. PubMed ID: 1353751
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy.
Closset J; Journe S; Mboti F; El Nakadi I; Gelin M
Hepatogastroenterology; 2008; 55(86-87):1818-23. PubMed ID: 19102400
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy.
Gouillat C; Chipponi J; Baulieux J; Partensky C; Saric J; Gayet B
Br J Surg; 2001 Nov; 88(11):1456-62. PubMed ID: 11683740
[TBL] [Abstract][Full Text] [Related]
15. Appraisal of two-staged pancreatoduodenectomy: its technical aspects and outcome.
Kubota K; Makuuchi M; Takayama T; Sakamoto Y; Harihara Y; Kimura W
Hepatogastroenterology; 2000; 47(31):269-74. PubMed ID: 10690620
[TBL] [Abstract][Full Text] [Related]
16. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
Barnett SP; Hodul PJ; Creech S; Pickleman J; Arahna GV
Am Surg; 2004 Mar; 70(3):222-6; discussion 227. PubMed ID: 15055845
[TBL] [Abstract][Full Text] [Related]
17. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.
Vanounou T; Pratt WB; Callery MP; Vollmer CM
J Am Coll Surg; 2007 Oct; 205(4):546-57. PubMed ID: 17903728
[TBL] [Abstract][Full Text] [Related]
18. [Results of use of sandostatin in pancreatoduodenal resections].
Skipenko OG; Voskresenskii OV; Shishlo LA; Shatverian GA; Timoshin AD; Movchun AA
Khirurgiia (Mosk); 1997; (2):39-44. PubMed ID: 9162768
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic juice output and amylase level in the drainage fluid after pancreatoduodenectomy in relation to leakage.
Hashimoto N; Ohyanagi H
Hepatogastroenterology; 2002; 49(44):553-5. PubMed ID: 11995494
[TBL] [Abstract][Full Text] [Related]
20. Effects of intra-arterial octreotide on pancreatic texture: a randomized controlled trial.
Belyaev O; Polle C; Herzog T; Munding J; Chromik AM; Meurer K; Tannapfel A; Bergmann U; Müller CA; Uhl W
Scand J Surg; 2013; 102(3):164-70. PubMed ID: 23963030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
